Pharmaceutical News

RSS

Study compares FK506 and rapamycin for Schwann cell migration, peripheral nerve regeneration

FK506 possesses a well-studied neuroregenerative effect, stimulating neurite extension in the presence of nerve growth factor in vitro, and enhancing nerve regeneration following nerve crush injury and isografting.

30 Aug 2014

$Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis$

Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis

Raloxifene is a U.S. Food and Drug Administration (FDA)-approved treatment for decreasing fracture risk in osteoporosis.

30 Aug 2014

InnoPharma receives FDA approval for generic DACOGEN

InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for decitabine for injection, a generic version of Eisai Inc.'s DACOGEN.

29 Aug 2014

Vasopressin more effective for cardiopulmonary resuscitation

Epinephrine has been shown to be a first-choice drug for cardiopulmonary resuscitation. Nevertheless, its β-adrenergic effect probably increases myocardial oxygen consumption and leads to severe cardiac and cerebral injuries; moreover, epinephrine does not elevate long-term survival rates.

29 Aug 2014

Irinotecan-based therapy improves survival rates for patients with stage III colon cancer

A subset of patients with stage III colon cancer had improved survival rates when treated with irinotecan-based therapy, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

29 Aug 2014

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

Decision Resources Group finds that the market for colorectal cancer (CRC) therapies will remain constant, at around $7.7 billion by 2023 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

28 Aug 2014

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Mylan Inc. today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration.

28 Aug 2014

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

Many African-Americans may not be getting effective doses of the HIV drug maraviroc, a new study from Johns Hopkins suggests. The initial dosing studies, completed before the drug was licensed in 2007, included mostly European-Americans, who generally lack a protein that is key to removing maraviroc from the body.

28 Aug 2014

THC may slow or halt progression of Alzheimer's disease

Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer's disease, a recent study from neuroscientists at the University of South Florida shows.

28 Aug 2014

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

Amgen today announced the U.S. Food and Drug Administration has granted priority review designation for ivabradine for the treatment of chronic heart failure (HF).

28 Aug 2014

TWi Pharmaceuticals obtains final approval from FDA for megestrol acetate 125mg/ml oral suspension

TWi Pharmaceuticals, Inc. today announced that it has received final approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for megestrol acetate 125mg/ml oral suspension, the generic equivalent to Par Pharmaceutical's Megace ES.

28 Aug 2014

Expanding age of eligibility for measles vaccination could have large effects on coverage in Africa

Expanding the age of eligibility for measles vaccination from 12 to 15 months could have potentially large effects on coverage in Africa, according to a new report published by Princeton University's Woodrow Wilson School of Public and International Affairs.

27 Aug 2014

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New national guidelines can improve the way statin drugs are prescribed to patients at risk for cardiovascular disease, a Yale University study has found.

27 Aug 2014

New ebook provides insights into understanding and demonstrating drug value in the current healthcare market

How are pharma, payers and patients utilizing evidence of real world outcomes to better understand and demonstrate drug value and improve patient care? How is the global market access environment changing and how is this impacting on pharmaceutical organisations? What does pharma need to know about the diverse payer landscape, alternative payment plans and communicating and influencing decision making?

26 Aug 2014

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

26 Aug 2014

ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

ZO Skin Health, Inc. is excited to reveal two new products developed by Zein Obagi, MD to further enhance the ZO Skin Health Circle continuum of care – ZO Medical C-Bright 10% Vitamin C Serum and ZO Medical Brightalive Non-Retinol Skin Brightener.

26 Aug 2014

Low dose of opioids including methadone effective for treatment of testosterone suppression

Treatment for opioid addiction tampers with the testosterone levels of male but not female opioid users, McMaster University research has shown.

26 Aug 2014

Research to understand how medical marijuana laws may influence overdose deaths

In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25 percent lower than in states where medical marijuana remains illegal, new research suggests.

26 Aug 2014

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

A team of scientists led by Research Associate Professor Motomi Osato and Professor Yoshiaki Ito from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) found that a drug originally designed for killing a limited type of cancer cells with DNA repair defects could potentially be used to treat leukaemia and other cancers.

26 Aug 2014

NEOMED gets $12 million to support academic researchers on drug development

NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.

26 Aug 2014

Pharmaceutical News

Study compares FK506 and rapamycin for Schwann cell migration, peripheral nerve regeneration

Raloxifene: FDA approved treatment for decreasing fracture risk in osteoporosis

InnoPharma receives FDA approval for generic DACOGEN

Vasopressin more effective for cardiopulmonary resuscitation

Irinotecan-based therapy improves survival rates for patients with stage III colon cancer

Colorectal cancer therapies market to remain constant at $7.7 billion by 2023

FDA accepts Mylan's ANDA filing for generic Copaxone 40 mg/mL

Study: Many HIV infected African-Americans may not be receiving effective doses of maraviroc drug

THC may slow or halt progression of Alzheimer's disease

Amgen's ivabradine receives FDA priority review designation for treatment of chronic heart failure

TWi Pharmaceuticals obtains final approval from FDA for megestrol acetate 125mg/ml oral suspension

Expanding age of eligibility for measles vaccination could have large effects on coverage in Africa

New guidelines can improve the way statin drugs prescribed to patients at cardiovascular risk

New ebook provides insights into understanding and demonstrating drug value in the current healthcare market

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

ZO Skin Health reveals two new ZO Medical formulations to address hyperpigmentation

Low dose of opioids including methadone effective for treatment of testosterone suppression

Research to understand how medical marijuana laws may influence overdose deaths

Drug to kill limited type of cancer cells with DNA repair defects could treat leukaemia

NEOMED gets $12 million to support academic researchers on drug development

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News